In this exclusive interview, Dr. Vinik shares his views on what matters in studying bariatric surgery outcomes, and why weight loss and effect on diabetes are not the key questions for him.

42 year old female, 5’ 4”, 275 lbs, BMI 47.2 kg/m2. History of hypertension, chronic low back pain, severe gastroesophageal reflux disease, depression and type 2 diabetes (diagnosed 2 years ago), and anxiety/depression. Medications include lisinopril 10 mg daily, oxycodone 5 mg TID prn, omeprazole 20 mg daily, metformin 500 mg BID, and paroxetine 20 mg daily. She has been actively working with her PCP on losing weight with diet modification and water aerobics but has only lost about 4% of her weight in the past 6 months. Current labs: (fasting) blood glucose 154 mg/dl, Hgb A1c 6.7 Creatinine 1.6, mg/dl and TSH of 3.6 U/ml. What is the best course of action?

Dr. Aaron Vinik joins Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida. In Part 6 of this Exclusive Interview, Steve asks Dr. Vinik his opinion on type 1 and SGLT-2s.

Dr. Aaron Vinik joins Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida. In Part 5 of this Exclusive Interview, Dr. Vinik explains the caution on the part of doctors to use the latest SGLT-2 medications despite apparent benefits.

Dr. Aaron Vinik joins Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida. In Part 3 of this Exclusive Interview, he explains the most important risk factors to look for when determining how to treat a patient. Aaron Vinik, MD, PhD, FCP, MACP, FACE is …

Dr. Aaron Vinik joins Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida In Part 2 of this Exclusive Interview, Dr. Vinik discusses using heart rate variability as a risk identifier in the treatment of patients with high blood glucose. Aaron Vinik, MD, PhD, FCP, MACP, …

In Part 1 of this Exclusive Interview, Dr. Aaron Vinik joins Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida to discuss the latest standards for bariatric surgery and the use of it to reverse the function of the autonomic nervous system. Aaron Vinik, MD, …

This past week it seems that the genomic testing company 23&ME has been on an advertising blitz. Maybe they feel that Independence Day is a great time for people to think about their heritage. It was interesting that after one of their commercials, there was one from a large cancer …

African American male, 63 years of age, type 2 diabetes, hypertension, strong family history of type 2 diabetes, hypertension and stroke. A1C is 6.7%. Blood pressure 160/96 HR 88, despite being on ACE-I and Beta Blocker.

In part 4 of this Exclusive Interview, Dr. Chous discusses his findings during a clinical trial of a multi-component supplement used to intervene in the development of diabetic retinopathy and improve visual function.